Published in Int J Mol Sci on November 17, 2014
A Western diet induced NAFLD in LDLR(-/)(-) mice is associated with reduced hepatic glutathione synthesis. Free Radic Biol Med (2016) 0.77
Clinical Study of Serum Homocysteine and Non-Alcoholic Fatty Liver Disease in Euglycemic Patients. Med Sci Monit (2016) 0.75
Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. Nutrients (2017) 0.75
Plasma Amino Acid Profile in Patients with Aortic Dissection. Sci Rep (2017) 0.75
Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study. Nutr J (2016) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis (2008) 3.69
Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest (2001) 3.24
Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J (1999) 2.96
Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med (2011) 2.34
Mammalian cysteine metabolism: new insights into regulation of cysteine metabolism. J Nutr (2006) 1.94
Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism (2010) 1.77
Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology (2013) 1.75
Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost (2000) 1.75
Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis (2012) 1.68
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol (2013) 1.49
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. J Gastroenterol Hepatol (2013) 1.38
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol (2010) 1.35
Contributions of hyperhomocysteinemia to atherosclerosis: Causal relationship and potential mechanisms. Biofactors (2009) 1.29
Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol (2003) 1.29
Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci (2013) 1.25
Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach. Nat Rev Gastroenterol Hepatol (2012) 1.19
Homocysteine and lipids: S-adenosyl methionine as a key intermediate. FEBS Lett (2009) 1.17
Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim Biophys Acta (2011) 1.11
Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol (2002) 1.10
A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol (2012) 1.08
Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab (2012) 1.02
Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2005) 1.02
Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci (2009) 1.00
High fat diet-induced non alcoholic fatty liver disease in rats is associated with hyperhomocysteinemia caused by down regulation of the transsulphuration pathway. Lipids Health Dis (2011) 0.98
Methionine deficiency and hepatic injury in a dietary steatohepatitis model. Dig Dis Sci (2007) 0.97
Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2009) 0.95
Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD). Nutr J (2013) 0.95
Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis. Clin Chim Acta (2005) 0.93
Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta (1999) 0.92
Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. Mol Metab (2014) 0.89
Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study. Stroke (2004) 0.89
Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes. Nutrition (2012) 0.86
Homocysteine, the bad thiol. Hepatology (2005) 0.86
Serum homocysteine levels in patients with nonalcoholic fatty liver disease. Ann Hepatol (2011) 0.85
Hyperhomocysteinemia induces liver injury in rat: Protective effect of folic acid supplementation. Biochim Biophys Acta (2006) 0.83
Effect of methionine-deficient and methionine-supplemented diets on the hepatic one-carbon and lipid metabolism in mice. Mol Nutr Food Res (2014) 0.81
Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease. J Nephrol (2014) 0.80
Multidrug resistance and cancer stem cells in neuroblastoma and hepatoblastoma. Int J Mol Sci (2013) 0.86